Acetylcholine receptors in dementia and mild cognitive impairment. - Wikidata - awgldk - TriplyDB

Acetylcholine receptors in dementia and mild cognitive impairment.

Acetylcholine receptors in dementia and mild cognitive impairment.

http://www.wikidata.org/entity/Q37070299

about

What can imaging tell us about cognitive impairment and dementia?Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT Cholinergic imaging in dementia spectrum disorders Neuroimaging biomarkers of neurodegenerative diseases and dementia Activities of nicotinic acetylcholine receptors modulate neurotransmission and synaptic architecture The relationship between associative learning, transfer generalization, and homocysteine levels in mild cognitive impairment.Brain imaging of nicotinic receptors in Alzheimer's disease.Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia.Nicotine effects in adolescence and adulthood on cognition and α₄β₂-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia.Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development.Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment.Clinical Perspective and Recent Development of PET Radioligands for Imaging Cerebral Nicotinic Acetylcholine Receptors.Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography.Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry.Muscarinic antagonist effects on executive control of attention.Overlooked Alzheimer's smoking gun?Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic α4β2 Receptor Availability in Alzheimer's Disease.Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects.The nicotinic acetylcholine receptor as a target for antidepressant drug development.Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.

P2860

Q26749292-60002A1D-070A-4FE8-9651-4ED167F8D67A Q26749755-EA05853E-956F-48F3-B228-FF9BE07AE645 Q26764933-575175B8-7B4D-4BAB-A439-46C2E2F9E79E Q27691820-B5E4E3B8-704D-46C2-8F3A-DACDAD1867E6 Q28083726-74CA4D5D-C479-4569-B183-AFC80C96676A Q34431347-64ADDF3A-2DE7-4838-B574-3F0D80050172 Q34496928-10648051-BF13-4B64-A678-3D8D02EB7077 Q34712689-C4397ECE-8126-47F3-BD61-F30F17BCF52E Q35547417-24AC3844-E897-4F24-8680-4BB3BC38F100 Q35840623-FD5A9C6A-1358-46F9-A7F6-D74B558F2F90 Q35995627-1A1DB0B5-37F2-4ED8-B1ED-72C0B0751B9E Q36020776-7D097FD6-834E-4F7F-A3F1-536D58D21A7D Q36994843-C6BD9501-8AC4-4E0D-BBAC-430DECD5F461 Q37188764-378D0927-8C48-4169-9B6B-E9C09625644D Q37386875-2CEFFC4D-5284-40CF-8E1D-540B17D53507 Q37419686-0CADD3DC-27B6-4339-BBC3-DBD98FAC3E05 Q37639158-E3D12AC8-933A-4370-A501-08E29E383EDB Q37651602-6A6AE8BE-EF60-409D-8A62-0577205185F3 Q37826637-1952F774-369B-457A-A9D8-17B302126F41 Q38166970-37DD63CE-516B-4BF5-8041-6FF74C6A120B Q38244707-4FBF78D9-295B-403D-9FB1-BCAF40E37D9E Q42843019-CC09FF44-8AD8-4835-875D-430B80BC61F8 Q43269051-A58A00D7-1FBC-4961-B424-3AFF7CD77727 Q44024738-8A32EA44-2356-45F0-8589-584EF50B18FA Q48009480-B26AB6FE-E822-4551-9E03-CB448DEA9EA6 Q48831751-1F36F040-0FC0-4527-8E0C-0CA40BF879EC Q51597754-B2B0537F-FA4A-4087-87B5-8AB2ABB9D049 Q55400177-4E0DCA56-6046-49F5-A361-AB77CDC2D24F

P2860

Acetylcholine receptors in dementia and mild cognitive impairment.

http://www.wikidata.org/entity/Q37070299

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Acetylcholine receptors in dementia and mild cognitive impairment.

@en

Acetylcholine receptors in dementia and mild cognitive impairment.

@nl

type

label

Acetylcholine receptors in dementia and mild cognitive impairment.

@en

Acetylcholine receptors in dementia and mild cognitive impairment.

@nl

prefLabel

Acetylcholine receptors in dementia and mild cognitive impairment.

@en

Acetylcholine receptors in dementia and mild cognitive impairment.

@nl

P1433

Q37070299-93B2E7BC-E18C-4F1B-94AA-AAF791696D37

P1476

Q37070299-596C1793-6161-4BE7-A0C9-67117768789E

P2093

Q37070299-7CA08196-C866-4D80-BF98-84EC463162B8

Q37070299-8C43419D-0A3A-440C-A54B-B6B44EBF00B3

Q37070299-B660BE95-464B-424B-B09B-F5CD5E89F12D

Q37070299-CC4A784B-C879-455E-B618-2D26BF760C7D

P2860

Q37070299-04EB09F9-7291-4E1C-8BA6-E1D028D73B6C

Q37070299-3CDA7AA2-431C-4E64-8223-DF47C54B281D

Q37070299-430C9983-5805-442A-8536-CD26296D9662

Q37070299-6AE869B5-BF7A-45D6-852C-D8CB783940F3

P2888

Q37070299-3992EAFA-15F3-478D-AFDF-5CAB87902E25

P304

Q37070299-FBA5E93D-229A-4381-A99D-FF53CF3EE6BB

P31

Q37070299-65939C0D-44D1-4577-BBED-963EB0C2E300

P356

Q37070299-7EC79F2C-8E8B-430C-B388-AAC7E7495BD2

P478

Q37070299-70DD6B20-7496-4B32-8E6D-079A740117D1

P50

Q37070299-B78FDA87-1B5F-49C2-BB00-992058097812

P577

Q37070299-7EB0B01D-6F1C-43A3-80F3-BE4CFF7B695C

P5875

Q37070299-ACC5962D-3EEE-42B7-BBA2-6B5A2F714CB1

P698

Q37070299-E51939B0-2663-49C7-9679-C952B81B0598

P921

Q37070299-70699B55-5E31-46A3-BA1E-C7EB942C465D

P356

S00259-007-0701-1

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Acetylcholine receptors in dementia and mild cognitive impairment

@en

P2093

Hermann-Josef Gertz

http://www.w3.org/2001/XMLSchema#string

Kai Kendziorra

http://www.w3.org/2001/XMLSchema#string

Osama Sabri

http://www.w3.org/2001/XMLSchema#string

Peter Brust

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss.

Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy.

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease.

P2888

s00259-007-0701-1

P304

S30-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-007-0701-1

http://www.w3.org/2001/XMLSchema#string

P478

35 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5623885

http://www.w3.org/2001/XMLSchema#string

P698

18228017

http://www.w3.org/2001/XMLSchema#string

P921